Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Events / Business / Molbio Diagnostics IPO price band set
Business IPO launch

Molbio Diagnostics IPO price band set

Analysis based on 15 articles · First reported Aug 05, 2026 · Last updated Aug 10, 2026

Sentiment
60
Attention
4
Articles
15
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The IPO is expected to attract significant investor interest given Molbio's strong growth and the growing demand for point-of-care diagnostics. The listing could boost the company's valuation and provide liquidity to existing investors, while also drawing attention to the Indian diagnostics sector.

Diagnostics Healthcare Medical Devices
Event Summary

Molbio Diagnostics Ltd, a Goa-based point-of-care molecular diagnostics company, has fixed a price band of Rs 768-807 per share for its initial public offering (IPO). The issue, valued at approximately Rs 930-940 crore, comprises a fresh issue of Rs 200 crore and an offer for sale (OFS) of up to 91.66 lakh shares by existing shareholders. The IPO will open for subscription on August 10, 2026, and close on August 12, with anchor investor bidding on August 7. The company plans to use the fresh proceeds for capital expenditure on an R&D facility and Centre of Excellence via its subsidiary Bigtec, and for plant and machinery at its manufacturing units in Goa and Visakhapatnam. Molbio reported strong financials for FY26, with revenue of Rs 1,445 crore and net profit of Rs 164-166 crore. The shares are expected to list on the BSE and NSE on August 17. The IPO is being managed by Kotak Mahindra Capital, Si Creva Capital Services, Jefferies, and Motilal Oswal Investment Advisors, with KFin Technologies as registrar. The company is backed by Temasek Holdings and Motilal Oswal Private Equity.

Key Actions
95 Behari Lal Engineering fixed price band
90 Molbio Diagnostics fixed price band
90 Shiprocket launched IPO
83 Milky Mist Dairy Food raised capital
80 Molbio Diagnostics reported financial results
70 Molbio Diagnostics planned R&D investment Bigtec
70 Molbio Diagnostics planned capex investment
70 International Finance Corporation invested anchor Molbio Diagnostics
60 Exxora Trading LLP sold shares
60 Chandrasekharan Raghuram sold shares
60 India Business Excellence Fund III sold shares
50 Kotak Mahindra Bank — Kotak Mahindra Capital Company appointed lead manager Molbio Diagnostics
50 Si Creva Capital Services appointed lead manager Molbio Diagnostics
50 Jefferies appointed lead manager Molbio Diagnostics
50 Motilal Oswal Investment Advisors appointed lead manager Molbio Diagnostics
+ 8 more actions View on Dashboard
Entities Involved
priv
Molbio Diagnostics
Molbio Diagnostics is the issuer of the IPO, which is expected to raise around Rs 930 crore. The company's strong financials and growth prospects are likely to attract investor interest, and the listing will provide it with additional capital for expansion.
Importance 100.0 Sentiment 70.0
priv
Temasek Holdings
Temasek Holdings, through its subsidiary V Sciences Investments, is a significant investor in Molbio Diagnostics. The IPO provides an opportunity for partial exit and is likely to generate positive returns on its investment.
Importance 60.0 Sentiment 60.0
priv
Motilal Oswal Private Equity
Motilal Oswal Private Equity, through India Business Excellence Fund III, is a key investor in Molbio Diagnostics. The IPO allows it to partially exit its stake, potentially realizing gains.
Importance 60.0 Sentiment 60.0
priv
Exxora Trading LLP
Exxora Trading LLP, a promoter entity, is selling shares in the OFS, reducing its stake. This provides liquidity and potential returns.
Importance 50.0 Sentiment 55.0
per
Chandrasekharan Raghuram
Dr Chandrasekharan Raghuram, a promoter, is selling shares in the OFS, reducing his stake. This provides liquidity and potential returns.
Importance 50.0 Sentiment 55.0
priv
India Business Excellence Fund III
India Business Excellence Fund III, managed by Motilal Oswal, is selling shares in the OFS, reducing its stake. This provides liquidity and potential returns.
Importance 50.0 Sentiment 55.0
priv
Jefferies
Jefferies is a book-running lead manager for the IPO, earning fees and enhancing its reputation.
Importance 40.0 Sentiment 50.0
priv
V Sciences Investments Private Limited
V Sciences Investments, a Temasek subsidiary, holds a stake in Molbio Diagnostics. The IPO may provide an opportunity for partial exit.
Importance 40.0 Sentiment 55.0
subs
Kotak Mahindra Bank — Kotak Mahindra Capital Company
Kotak Mahindra Capital is a book-running lead manager for the IPO, earning fees and enhancing its reputation in the capital markets.
Importance 40.0 Sentiment 50.0
priv
Si Creva Capital Services
Si Creva Capital Services is a book-running lead manager for the IPO, earning fees and enhancing its reputation.
Importance 40.0 Sentiment 50.0
priv
Motilal Oswal Investment Advisors
Motilal Oswal Investment Advisors is a book-running lead manager for the IPO, earning fees and enhancing its reputation.
Importance 40.0 Sentiment 50.0
cnt
India
India is the home market for Molbio Diagnostics and the IPO is part of the country's vibrant capital markets activity, reflecting the growth of its healthcare sector.
Importance 30.0 Sentiment 60.0
priv
Bigtec
Bigtec, a wholly owned subsidiary of Molbio, will receive funds from the IPO to set up an R&D facility and Centre of Excellence, supporting the company's innovation efforts.
Importance 30.0 Sentiment 50.0
subs
Dhoot Transmission — Dhoot Transmission UK
Dhoot Transmission — Dhoot Transmission UK is launching its own IPO on the same day, which may compete for investor attention but is otherwise unaffected.
Importance 20.0 Sentiment 40.0
exch
JSE Limited
JSE Limited will list Molbio Diagnostics shares, adding to its trading volumes and activity.
Importance 20.0 Sentiment 50.0
+ 4 more entities View on Dashboard
Relationships
Temasek Holdings related ↔ Kotak Mahindra Bank — Kotak Mahindra Capital Company
Temasek Holdings related ↔ Si Creva Capital Services
Kotak Mahindra Bank — Kotak Mahindra Capital Company related ↔ Si Creva Capital Services
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.